Ethanol modulates the interaction of the endogenous neurosteroid allopregnanolone with the α1β2γ2L GABAA receptor

被引:15
作者
Akk, Gustav [1 ]
Li, Ping [1 ]
Manion, Brad D. [1 ]
Evers, Alex S. [1 ]
Steinbach, Joe Henry [1 ]
机构
[1] Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA
关键词
D O I
10.1124/mol.106.029942
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have examined alpha 1 beta 2 gamma 2L GABA(A) receptor modulation by the endogenous steroids allopregnanolone (3 alpha 5 alpha P), pregnenolone sulfate, and beta-estradiol in the absence and presence of ethanol. Coapplication of 0.1 to 1% (17-170 mM) ethanol influenced receptor modulation by 3 alpha 5 alpha P but not that by pregnenolone sulfate or beta-estradiol. One of the three kinetic effects evident in channel potentiation by 3 alpha 5 alpha P, prolongation of the longest-lived open time component (OT3), was affected by ethanol with the midpoint of its dose-response curve moved to lower steroid concentrations by 2 orders of magnitude without significantly affecting the maximal effect. Manipulations designed to affect the ability of 3 alpha 5 alpha P to prolong OT3 also affected OT3 prolongation in the presence of ethanol. A mutation to the gamma 2 subunit, which reduces the ability of 3 alpha 5 alpha P to prolong OT3, also reduces the interaction between ethanol and 3 alpha 5 alpha P. And the presence of the competitive steroid antagonist (3 alpha,5 alpha)-17-phenylandrost-16-en-3-ol (17-PA) diminishes the positive interaction between ethanol and 3 alpha 5 alpha P on the GABA(A) receptor. Together, the findings suggest that steroid interactions with the classic steroid binding site underlie the effect seen in the presence of ethanol, and that ethanol acts by increasing the affinity of 3 alpha 5 alpha P for the site. Tadpole behavioral assays showed that the presence of 3 alpha 5 alpha P at a concentration ineffective at causing changes in tadpole behavior shifted the ethanol dose-response curve for loss of righting reflex to lower concentrations and that this effect was neutralized by coapplication of 17-PA with 3 alpha 5 alpha P.
引用
收藏
页码:461 / 472
页数:12
相关论文
共 37 条
  • [1] Neurosteroid access to the GABAA receptor
    Akk, G
    Shu, HJ
    Wang, C
    Steinbach, JH
    Zorumski, CF
    Covey, DF
    Mennerick, S
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (50) : 11605 - 11613
  • [2] Neuroactive steroids have multiple actions to potentiate GABAA receptors
    Akk, G
    Bracamontes, JR
    Covey, DF
    Evers, A
    Dao, T
    Steinbach, JH
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 558 (01): : 59 - 74
  • [3] Low doses of ethanol and a neuroactive steroid positively interact to modulate rat GABAA receptor function
    Akk, G
    Steinbach, JH
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2003, 546 (03): : 641 - 646
  • [4] Contributions of the non-α subunit residues (loop D) to agonist binding and channel gating in the muscle nicotinic acetylcholine receptor
    Akk, G
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2002, 544 (03): : 695 - 705
  • [5] Pregnenolone sulfate block of GABAA receptors:: mechanism and involvement of a residue in the M2 region of the α subunit
    Akk, G
    Bracamontes, J
    Steinbach, JH
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2001, 532 (03): : 673 - 684
  • [6] Neurosteroids: A novel function of the brain
    Baulieu, EE
    [J]. PSYCHONEUROENDOCRINOLOGY, 1998, 23 (08) : 963 - 987
  • [7] Neurosteroids:: Endogenous regulators of the GABAA receptor
    Belelli, D
    Lambert, JJ
    [J]. NATURE REVIEWS NEUROSCIENCE, 2005, 6 (07) : 565 - 575
  • [8] Bianchi MT, 2003, J NEUROSCI, V23, P10934
  • [9] Deletion of the α1 or β2 subunit of GABAA receptors reduces actions of alcohol and other drugs
    Blednov, YA
    Jung, S
    Alva, H
    Wallace, D
    Rosahl, T
    Whiting, PJ
    Harris, RA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01) : 30 - 36
  • [10] The δ subunit of γ-aminobutyric acid type A receptors does not confer sensitivity to low concentrations of ethanol
    Borghese, CM
    Stórustovu, SI
    Ebert, B
    Herd, MB
    Belelli, D
    Lambert, JJ
    Marshall, G
    Wafford, KA
    Harris, RA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03) : 1360 - 1368